Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M LATORRE

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
Revista De Neurologia|July 23, 2011
[Predisposing factors affecting drop-out rates in preventive treatment in a series of patients with migraine]Manuel Gracia-Naya, Sonia Santos-Lasaosa, Consuelo Ríos-Gómez, et al.
Journal of Veterinary Medical Education|April 21, 2007
How useful is plastination in learning anatomy?Rafael M Latorre, Mari P García-Sanz, Matilde Moreno, et al.
Nutritional Neuroscience|May 8, 2018
The protective effect of extra-virgin olive oil in the experimental model of multiple sclerosis in the ratC Conde, B M Escribano, E Luque, et al.
Journal of Medicinal Chemistry|December 2, 1999
5-(Tryptophyl)amino-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-based potent and selective CCK(1) receptor antagonists: structural modifications at the tryptophan domainJ M Bartolomé-Nebreda, I Gómez-Monterrey, M T García-López, et al.
Journal of Medicinal Chemistry|June 19, 2001
5-(Tryptophyl)amino-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-based potent and selective CCK(1)receptor antagonists: structure-activity relationship studies on the substituent at N2-positionJ M Bartolomé-Nebreda, R Patiño-Molina, M Martín-Martínez, et al.
Revista De Neurologia|February 25, 2012
[A study to compare independent groups of patients with episodic migraine who were treated preventively with flunarizine or nadolol]M Gracia-Naya, M Huerta-Villanueva, C Rios, et al.
European Journal of Internal Medicine|February 4, 2018
Factors reducing omalizumab response in severe asthmaB Sposato, M Scalese, M Milanese, et al.
Revista De Neurologia|October 25, 2014
[Does medication abuse in patients with chronic migraine influence the effectiveness of preventive treatment with topiramate?]M Gracia-Naya, N Hernando-Quintana, A M Latorre-Jimenez, et al.
Revista De Neurologia|May 6, 2010
[Comparative study of the effectiveness of topiramate and nadolol in the preventive treatment of episodic migraine in independent series of patients]Manuel Gracia-Naya, Mariano Huerta-Villanueva, Consuelo Ríos-Gómez, et al.
Nature Ecology & Evolution|August 8, 2024
Century-long timelines of herbarium genomes predict plant stomatal response to climate changePatricia L M Lang, Joel M Erberich, Lua Lopez, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Revista De Neurologia|July 23, 2011
[Predisposing factors affecting drop-out rates in preventive treatment in a series of patients with migraine]Manuel Gracia-Naya, Sonia Santos-Lasaosa, Consuelo Ríos-Gómez, et al.
Journal of Veterinary Medical Education|April 21, 2007
How useful is plastination in learning anatomy?Rafael M Latorre, Mari P García-Sanz, Matilde Moreno, et al.
Nutritional Neuroscience|May 8, 2018
The protective effect of extra-virgin olive oil in the experimental model of multiple sclerosis in the ratC Conde, B M Escribano, E Luque, et al.
Journal of Medicinal Chemistry|December 2, 1999
5-(Tryptophyl)amino-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-based potent and selective CCK(1) receptor antagonists: structural modifications at the tryptophan domainJ M Bartolomé-Nebreda, I Gómez-Monterrey, M T García-López, et al.
Journal of Medicinal Chemistry|June 19, 2001
5-(Tryptophyl)amino-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-based potent and selective CCK(1)receptor antagonists: structure-activity relationship studies on the substituent at N2-positionJ M Bartolomé-Nebreda, R Patiño-Molina, M Martín-Martínez, et al.
Revista De Neurologia|February 25, 2012
[A study to compare independent groups of patients with episodic migraine who were treated preventively with flunarizine or nadolol]M Gracia-Naya, M Huerta-Villanueva, C Rios, et al.
European Journal of Internal Medicine|February 4, 2018
Factors reducing omalizumab response in severe asthmaB Sposato, M Scalese, M Milanese, et al.
Revista De Neurologia|October 25, 2014
[Does medication abuse in patients with chronic migraine influence the effectiveness of preventive treatment with topiramate?]M Gracia-Naya, N Hernando-Quintana, A M Latorre-Jimenez, et al.
Revista De Neurologia|May 6, 2010
[Comparative study of the effectiveness of topiramate and nadolol in the preventive treatment of episodic migraine in independent series of patients]Manuel Gracia-Naya, Mariano Huerta-Villanueva, Consuelo Ríos-Gómez, et al.
Nature Ecology & Evolution|August 8, 2024
Century-long timelines of herbarium genomes predict plant stomatal response to climate changePatricia L M Lang, Joel M Erberich, Lua Lopez, et al.
Pageof 15